Predictors of switching antipsychotic medications in the treatment of schizophrenia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Predictors of switching antipsychotic medications in the treatment of schizophrenia ; volume:10 ; number:1 ; day:28 ; month:9 ; year:2010 ; pages:1-11 ; date:12.2010
BMC psychiatry ; 10, Heft 1 (28.9.2010), 1-11, 12.2010
- Creator
-
Nyhuis, Allen W.
- Contributor
-
Faries, Douglas E.
Ascher-Svanum, Haya
Stauffer, Virginia L.
Kinon, Bruce J.
SpringerLink (Online service)
- DOI
-
10.1186/1471-244X-10-75
- URN
-
urn:nbn:de:1111-2016030430156
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nyhuis, Allen W.
- Faries, Douglas E.
- Ascher-Svanum, Haya
- Stauffer, Virginia L.
- Kinon, Bruce J.
- SpringerLink (Online service)
Other Objects (12)
Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
Comparative meta-analysis of the neurotransmitter alterations by antipsychotic medications
Exploring the interplay of psychiatric symptoms, antipsychotic medications, side effects, employment status, and quality of life in Chronic Schizophrenia
Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Gender differences in the use of atypical antipsychotic medications for ICU delirium
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment
Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications
Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
Comparative meta-analysis of the neurotransmitter alterations by antipsychotic medications
Exploring the interplay of psychiatric symptoms, antipsychotic medications, side effects, employment status, and quality of life in Chronic Schizophrenia
Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Gender differences in the use of atypical antipsychotic medications for ICU delirium
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment
Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications
Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
Comparative meta-analysis of the neurotransmitter alterations by antipsychotic medications
Exploring the interplay of psychiatric symptoms, antipsychotic medications, side effects, employment status, and quality of life in Chronic Schizophrenia
Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Gender differences in the use of atypical antipsychotic medications for ICU delirium
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment